Published in Graefes Arch Clin Exp Ophthalmol on October 01, 1995
The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation. J Virol (1998) 2.18
Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival. J Virol (2001) 2.17
The probability of in vivo reactivation of herpes simplex virus type 1 increases with the number of latently infected neurons in the ganglia. J Virol (1998) 1.84
HSV-1 genome subnuclear positioning and associations with host-cell PML-NBs and centromeres regulate LAT locus transcription during latency in neurons. PLoS Pathog (2012) 0.98
Increased neurovirulence and reactivation of the herpes simplex virus type 1 latency-associated transcript (LAT)-negative mutant dLAT2903 with a disrupted LAT miR-H2. J Neurovirol (2015) 0.78
Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J Virol (1998) 2.48
RNA complementary to herpes simplex virus type 1 ICP0 gene demonstrated in neurons of human trigeminal ganglia. J Virol (1988) 2.24
Phosphorylation of varicella-zoster virus open reading frame (ORF) 62 regulatory product by viral ORF 47-associated protein kinase. J Virol (1994) 1.99
Cell lines containing varicella-zoster virus open reading frame 62 and expressing the "IE" 175 protein complement ICP4 mutants of herpes simplex virus type 1. J Virol (1988) 1.78
The UL37 protein of herpes simplex virus type 1 is associated with the tegument of purified virions. Virology (1995) 1.42
Varicella-zoster virus open reading frame 4 encodes a transcriptional activator that is functionally distinct from that of herpes simplex virus homology ICP27. J Virol (1994) 1.32
Putative glycoprotein gene of varicella-zoster virus with variable copy numbers of a 42-base-pair repeat sequence has homology to herpes simplex virus glycoprotein C. J Virol (1986) 1.31
A comparison of enzyme immunoassay and polymerase chain reaction with the clinical examination for diagnosing ocular herpetic disease. Ophthalmology (1993) 1.24
Inversion and circularization of the varicella-zoster virus genome. J Virol (1985) 1.17
Host species and strain differences affect the ability of an HSV-1 ICP0 deletion mutant to establish latency and spontaneously reactivate in vivo. Virology (1990) 1.17
Antigenic and biochemical analysis of gB of herpes simplex virus type 1 and type 2 and of cross-reacting glycoproteins induced by bovine mammillitis virus and equine herpesvirus type 1. J Gen Virol (1985) 1.14
Further characterization of a rat model of varicella zoster virus-associated pain: Relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs. Neuroscience (2006) 1.14
Trigeminal ganglion neurons affect corneal epithelial phenotype. Influence on type VII collagen expression in vitro. Invest Ophthalmol Vis Sci (1993) 1.08
A 5-year evaluation of the adenoclone test for the rapid diagnosis of adenovirus from conjunctival swabs. Cornea (1996) 1.08
Transcription from varicella-zoster virus gene 67 (glycoprotein IV). J Virol (1992) 1.06
HSV-1 corneal latency. Invest Ophthalmol Vis Sci (1991) 0.99
Prolonged recoverability of desiccated adenovirus type 19 from various surfaces. Ophthalmology (1990) 0.97
Immunity in strain 2 guinea-pigs inoculated with vaccinia virus recombinants expressing varicella-zoster virus glycoproteins I, IV, V or the protein product of the immediate early gene 62. J Gen Virol (1992) 0.96
Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model. Invest Ophthalmol Vis Sci (1994) 0.94
Isolation of human adenovirus type 5 variants resistant to the antiviral cidofovir. Invest Ophthalmol Vis Sci (1996) 0.93
A fast, simple reactivation method for the study of HSV-1 latency in the rabbit ocular model. Invest Ophthalmol Vis Sci (1990) 0.92
A detailed analysis of transcripts mapping to varicella zoster virus gene 14 (glycoprotein V). Virology (1991) 0.92
Lomefloxacin is an effective treatment of experimental bacterial keratitis. Cornea (2001) 0.92
Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes. J Immunol (1997) 0.92
Anatomy of the varicella-zoster virus open-reading frame 4 promoter. J Infect Dis (1998) 0.92
Evidence for DNA binding activity of numatrin (B23), a cell cycle-regulated nuclear matrix protein. Biochim Biophys Acta (1990) 0.91
Multiple adenoviral serotypes demonstrate host range extension in the New Zealand rabbit ocular model. Invest Ophthalmol Vis Sci (1998) 0.91
The effects of topical nonsteroidal anti-inflammatory drugs on adenoviral replication. Arch Ophthalmol (1998) 0.91
Inhibitory effect of (S)-HPMPC, (S)-HPMPA, and 2'-nor-cyclic GMP on clinical ocular adenoviral isolates is serotype-dependent in vitro. Antiviral Res (1991) 0.89
An ocular model of adenovirus type 5 infection in the NZ rabbit. Invest Ophthalmol Vis Sci (1992) 0.89
Adenoviral ocular isolates demonstrate serotype-dependent differences in in vitro infectivity titers and clinical course. Cornea (1995) 0.85
Evaluation of the shell vial technique for detection of ocular adenovirus. Community Ophthalmologists of Pittsburgh, Pennsylvania. Ophthalmology (1999) 0.85
An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa. Ophthalmology (2001) 0.85
A novel cell-associated protection assay demonstrates the ability of certain antibiotics to protect ocular surface cell lines from subsequent clinical Staphylococcus aureus challenge. Antimicrob Agents Chemother (2011) 0.85
The survival of adenovirus in multidose bottles of topical fluorescein. Am J Ophthalmol (1998) 0.84
The effects of corticosteroids of adenoviral replication. Arch Ophthalmol (1996) 0.84
RPS Adeno Detector. Ophthalmology (2009) 0.84
A Rho-associated protein kinase: differentially distributed in limbal and corneal epithelia. Invest Ophthalmol Vis Sci (1998) 0.84
Experimental laser-assisted in situ keratomileusis induces the reactivation of latent herpes simplex virus. Am J Ophthalmol (2001) 0.83
The antiviral resistance and replication of cidofovir-resistant adenovirus variants in the New Zealand White rabbit ocular model. Invest Ophthalmol Vis Sci (2001) 0.83
The disinfection of contact lenses contaminated with adenovirus. Am J Ophthalmol (2001) 0.82
The effect of alpha blockade on iontophoresis-induced ocular shedding of latent HSV-1 W in different host animals. Curr Eye Res (1990) 0.81
2'-nor-cGMP, a new cyclic derivative of 2'NDG, inhibits HSV-1 replication in vitro and in the mouse keratitis model. Curr Eye Res (1987) 0.81
Topical corticosteroids reverse the antiviral effect of topical cidofovir in the Ad5-inoculated New Zealand rabbit ocular model. Invest Ophthalmol Vis Sci (1997) 0.80
Valacyclovir inhibits recovery of ocular HSV-1 after experimental reactivation by excimer laser keratectomy. Cornea (1999) 0.79
The antiviral effects of rose bengal and fluorescein. Arch Ophthalmol (1987) 0.79
A herpes simplex type 1 ICPO deletion mutant demonstrates diminished pathogenicity during acute ocular infection in different host animals. Invest Ophthalmol Vis Sci (1990) 0.79
Immunization with the immediate-early tegument protein (open reading frame 62) of varicella-zoster virus protects guinea pigs against virus challenge. J Virol (1993) 0.79
Pretreatment with topical 0.1% (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine inhibits adenovirus type 5 replication in the New Zealand rabbit ocular model. Cornea (1992) 0.78
Efficacy of glycoprotein inhibitors alone and in combination with trifluridine in the treatment of murine herpetic keratitis. Curr Eye Res (1986) 0.78
Timolol promotes reactivation of latent HSV-1 in the mouse iontophoresis model. Invest Ophthalmol Vis Sci (1987) 0.78
Nuclear retinoic acid receptors in the lacrimal gland. Curr Eye Res (1995) 0.77
Herpesvirus inoculation of cornea. Am J Ophthalmol (1984) 0.77
Recovery of a latent HSV-1 thymidine kinase negative strain following iontophoresis and co-cultivation in the ocularly-infected rabbit model. Curr Eye Res (1986) 0.76
Valacyclovir inhibition of recovery of ocular herpes simplex virus type 1 after experimental reactivation by laser in situ keratomileusis. J Cataract Refract Surg (2001) 0.76
HSV-1 latency: thymidine kinase requirement and the round-trip theory. Curr Eye Res (1987) 0.75
Replication of ocular isolates of human adenovirus is serotype-dependent in rabbit corneal organ culture. Curr Eye Res (1991) 0.75
Vanadate promotes reactivation and iontophoresis-induced ocular shedding of latent HSV-1 W in different host animals. Curr Eye Res (1990) 0.75
HSV-1 thymidine kinase negative vaccine: pathogenicity, protection, and perils. Curr Eye Res (1987) 0.75
Gene structure of chick lumican and identification of the first exon. Biochim Biophys Acta (1998) 0.75
Defective transport of herpes simplex virus glycoprotein in interferon-treated cells: role of intracellular pH. J Interferon Res (1994) 0.75
The synthesis and immunogenicity of varicella-zoster virus glycoprotein E and immediate-early protein (IE62) expressed in recombinant herpes simplex virus-1. Antiviral Res (1997) 0.75